US Senate debates AI regulation as imaging AI firms see funding and labs drive adoption, amid aging IT causing security concerns.
Key Details
- 1Senate Republicans are split over federal vs. state control of AI regulation, with some pushing a 10-year federal moratorium.
- 295% of healthcare IT leaders report using outdated systems; 59% face tech downtime and 45% cite security vulnerabilities.
- 3Pathology labs are adopting AI, with 25% citing improved diagnosis accuracy and >30% valuing efficiency gains.
- 4Recent radiology/AI start-ups raised $101M (referral simplification) and $32M (imaging AI firm HOPPR, led by notable radiologists).
- 5AI-driven ransomware threats are rising, prompting calls for improved healthcare IT security.
- 6AI is predicted to impact healthcare employment less than other sectors due to elasticity of healthcare demand.
Why It Matters
Major regulatory, security, and infrastructure shifts will directly impact adoption, safety, and market growth for imaging AI. The influx of funding and recognition among labs signals ongoing acceleration of radiology and pathology AI solutions, even as systemic IT weaknesses pose ongoing risks.
Source
AI in Healthcare
Related News
•AI in Healthcare
FDA Seeks Real-World Performance Insights on AI Medical Devices
FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
•Radiology Business
Analysis Finds Lax Reporting on Key Safety Data in FDA-Cleared AI Devices
Less than 30% of FDA-cleared AI devices shared key safety and adverse event data before approval, raising regulatory concerns.
•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.